PMID- 32777475 OWN - NLM STAT- MEDLINE DCOM- 20210915 LR - 20211204 IS - 1873-6823 (Electronic) IS - 0741-8329 (Linking) VI - 89 DP - 2020 Dec TI - Prenatal alcohol exposure and maternal glutamine supplementation alter the mTOR signaling pathway in ovine fetal cerebellum and skeletal muscle. PG - 93-102 LID - S0741-8329(20)30263-9 [pii] LID - 10.1016/j.alcohol.2020.08.002 [doi] AB - Prenatal alcohol exposure causes fetal neurodevelopmental damage and growth restriction. Among regions of the brain, the cerebellum is the most vulnerable to developmental alcohol exposure. Despite vast research in the field, there is still a need to identify specific mechanisms by which alcohol causes this damage in order to design effective therapeutic interventions. The mammalian target of rapamycin (mTOR) is known to be associated with axonal regeneration, dendritic arborization, synaptic plasticity, cellular growth, autophagy, and many other cellular processes. Glutamine and glutamine-related amino acids play a key role in fetal development and are known to alter the mTOR pathway; recent research has shown that disturbances in their bioavailability and signaling pathways may mediate adverse effects of prenatal alcohol exposure. This study investigated the role of the mTOR signaling pathway in the fetal cerebellum and skeletal muscle after third trimester-equivalent prenatal alcohol exposure and maternal l-glutamine (GLN) supplementation using a sheep model. Fetal cerebella and skeletal muscles were sampled for Western blot analysis of mTOR and its downstream targets S6 kinase and eukaryotic initiation factor 4E-bindin protein (4E-BP1). The expression of cerebellar phosphorylated mTOR relative to the total mTOR was elevated in the alcohol+GLN group compared to the saline and GLN groups. Alcohol exposure increased the ratio of phosphorylated S6K to total S6K in fetal cerebellum, and no significant effect of GLN supplementation was observed. On contrary, maternal GLN supplementation reduced the activation of mTOR and S6K in fetal skeletal muscle, possibly to make GLN and other amino acids available for use by other organs. These findings suggest prenatal alcohol exposure and maternal GLN supplementation during the third trimester-equivalent alter the mTOR signaling cascade, which plays a possible key role in alcohol-induced developmental damage. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Sawant, Onkar B AU - Sawant OB AD - Department of Veterinary Physiology and Pharmacology and Michael E. DeBakey Institute, Texas A&M University, College Station, TX, 77843, United States. FAU - Meng, Cong AU - Meng C AD - Department of Veterinary Physiology and Pharmacology and Michael E. DeBakey Institute, Texas A&M University, College Station, TX, 77843, United States. FAU - Wu, Guoyao AU - Wu G AD - Department of Animal Science, Texas A&M University, College Station, TX, 77843, United States. FAU - Washburn, Shannon E AU - Washburn SE AD - Department of Veterinary Physiology and Pharmacology and Michael E. DeBakey Institute, Texas A&M University, College Station, TX, 77843, United States. Electronic address: swashburn@cvm.tamu.edu. LA - eng GR - K08 AA018166/AA/NIAAA NIH HHS/United States GR - R01 AA010940/AA/NIAAA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20200807 PL - United States TA - Alcohol JT - Alcohol (Fayetteville, N.Y.) JID - 8502311 RN - 0RH81L854J (Glutamine) RN - 3K9958V90M (Ethanol) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Cerebellum/*drug effects/metabolism MH - Dietary Supplements MH - Ethanol/*adverse effects MH - Female MH - *Glutamine/administration & dosage MH - Muscle, Skeletal/*drug effects/metabolism MH - Phosphorylation MH - Pregnancy MH - *Prenatal Exposure Delayed Effects/metabolism MH - Ribosomal Protein S6 Kinases/metabolism MH - Sheep MH - Signal Transduction/*drug effects MH - TOR Serine-Threonine Kinases/metabolism OTO - NOTNLM OT - alcohol OT - cerebellum OT - glutamine OT - mTOR OT - teratogenicity EDAT- 2020/08/11 06:00 MHDA- 2021/09/16 06:00 CRDT- 2020/08/11 06:00 PHST- 2020/02/11 00:00 [received] PHST- 2020/08/04 00:00 [revised] PHST- 2020/08/04 00:00 [accepted] PHST- 2020/08/11 06:00 [pubmed] PHST- 2021/09/16 06:00 [medline] PHST- 2020/08/11 06:00 [entrez] AID - S0741-8329(20)30263-9 [pii] AID - 10.1016/j.alcohol.2020.08.002 [doi] PST - ppublish SO - Alcohol. 2020 Dec;89:93-102. doi: 10.1016/j.alcohol.2020.08.002. Epub 2020 Aug 7.